Newsletter
June 12, 2019
Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes
ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:
(i) the cultivation of the cannabis spp. for medical and scientific purposes; and
(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.
For further information, click below to access our full newsletter.
Last related news
April 28, 2022
Have you heard about the Web 3.0?
Web 3.0 is the new global trend that will impact modern society and the way people relate to the internet. It refers … Have you heard about the Web 3.0?
March 28, 2022
Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events
On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving … Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events
February 11, 2022
Data Protection becomes a fundamental right in Brazil
Yesterday (Feb. 10, 2022), the Brazilian Senate approved the Constitutional Amendment no. 115/2022, originated in the Proposal for Constitutional Amendment no. 17/2019, … Data Protection becomes a fundamental right in Brazil